Phase 3 Study of Prasugrel vs High Dose (150 mg) Clopidogrel in Clopidogrel Resistant Patients Post Coronary Angioplasty.
Phase of Trial: Phase III
Latest Information Update: 29 Aug 2010
At a glance
- Drugs Prasugrel (Primary) ; Clopidogrel
- Indications Acute coronary syndromes; Cardiovascular disorders; Coronary artery disease; Coronary thrombosis
- Focus Pharmacodynamics; Pharmacogenomic
- 29 Aug 2010 Results presented at the Annual Congress of the European Society of Cardiology (ESC) 2010 meeting.
- 23 Aug 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 01 Jul 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.